Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mikiko Harada is active.

Publication


Featured researches published by Mikiko Harada.


PLOS ONE | 2017

Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study

Takashi Miura; Masatoshi Minamisawa; Yasushi Ueki; Naoyuki Abe; Hitoshi Nishimura; Naoto Hashizume; Tomoaki Mochidome; Mikiko Harada; Yasutaka Oguchi; Koji Yoshie; Wataru Shoin; Tatsuya Saigusa; Soichiro Ebisawa; Hirohiko Motoki; Jun Koyama; Uichi Ikeda; Koichiro Kuwahara

Background The ankle—brachial index (ABI) is a marker of generalized atherosclerosis and is predictive of future cardiovascular events. However, few studies have assessed its relation to long-term future cardiovascular events, especially in patients with borderline ABI. We therefore evaluated the relationship between long-term future cardiovascular events and ABI. Methods In the IMPACT-ABI study, a single-center, retrospective cohort study, we enrolled 3131 consecutive patients (67 ± 13 years; 82% male) hospitalized for cardiovascular disease and measured ABI between January 2005 and December 2012. After excluding patients with an ABI > 1.4, the remaining 3056 patients were categorized as having low ABI (≤ 0.9), borderline ABI (0.91–0.99), or normal ABI (1.00–1.40). The primary endpoint was MACE (cardiovascular death, myocardial infarction [MI] and stroke). The secondary endpoints were cardiovascular death, MI, stroke, admission due to heart failure, and major bleeding. Results During a 4.8-year mean follow-up period, the incidences of MACE (low vs. borderline vs. normal: 32.9% vs. 25.0% vs. 14.6%, P<0.0001) and cardiovascular death (26.2% vs. 18.7% vs. 8.9%, P<0.0001) differed significantly across ABIs. The incidences of stroke (9.1% vs. 8.6% vs. 4.8%, P<0.0001) and heart failure (25.7% vs. 20.8% vs. 8.9%, P<0.0001) were significantly higher in the low and borderline ABI groups than in the normal ABI group. But the incidences of MI and major bleeding were similar in the borderline and normal ABI groups. The hazard ratios for MACE adjusted for traditional atherosclerosis risk factors were significantly higher in patients with low and borderline ABI than those with normal ABI (HR, 1.93; 95%CI: 1.44–2.59, P < 0.0001, HR, 1.54; 95% CI: 1.03–2.29, P = 0.035). Conclusions The incidence of long-term adverse events was markedly higher among patients with low or borderline ABI than among those with normal ABI. This suggests that more attention should be paid to patients with borderline ABIs, especially with regard to cardiovascular death, stroke, and heart failure.


International Heart Journal | 2017

Prognostic Impact of Diastolic Wall Strain in Patients at Risk for Heart Failure

Masatoshi Minamisawa; Takashi Miura; Hirohiko Motoki; Yasushi Ueki; Kunihiko Shimizu; Wataru Shoin; Mikiko Harada; Tomoaki Mochidome; Koji Yoshie; Yasutaka Oguchi; Naoto Hashizume; Hitoshi Nishimura; Naoyuki Abe; Soichiro Ebisawa; Atsushi Izawa; Jun Koyama; Uichi Ikeda

Diastolic wall strain (DWS) is based on the linear elastic theory, according to which decreased wall thinning during diastole reflects reduced left ventricular compliance and thus increased diastolic stiffness. Increased diastolic stiffness as assessed by DWS is associated with a worse prognosis in patients who have heart failure (HF) with preserved ejection fraction. However, there are no data about the prognostic value of DWS derived by M-mode echocardiography in patients at risk for HF. We retrospectively enrolled 1829 consecutive patients without prior HF who were hospitalized for cardiovascular (CV) diseases in our hospital between 2005 and 2012. Patients were divided into two groups stratified by DWS (median value 0.34). The study endpoint was the composite of major adverse cardiovascular events (MACE), including all-cause death, myocardial infarction, stroke, and hospitalization for HF. Over a 4.2-year median follow-up, adverse events were observed in 322 patients (17.6%). In Kaplan-Meier analysis, patients with low DWS (≤ 0.34, n = 915) showed worse prognoses than those with high DWS (> 0.34, n = 914) (MACE incidence 39.4% versus 31.9%, P = 0.011). In multivariate Cox proportional hazards analysis after the adjustment for age, sex, and echocardiographic parameters, low DWS (≤ 0.34) was significantly associated with the incidence of MACE (hazard ratio: 1.26, 95% confidence interval: 1.01-1.59; P = 0 .045). In patients without prior HF, DWS is an independent predictor of MACE. Simple assessment of DWS might improve risk stratification for CV events in those patients.


Journal of Cardiology | 2017

Importance of cystatin C and uric acid levels in the association of cardiometabolic risk factors in Japanese junior high school students

Mikiko Harada; Atsushi Izawa; Hiroya Hidaka; Keisuke Nakanishi; Fumiko Terasawa; Hirohiko Motoki; Yoshikazu Yazaki; Uichi Ikeda; Minoru Hongo

BACKGROUND Serum cystatin C (CysC), a novel marker of renal function, is associated with the components of metabolic syndrome in adults. Little is known about the utility of CysC and its association with cardiometabolic risks in young subjects. METHODS AND RESULTS In a cohort of 454 Japanese junior high school students, the distribution of serum CysC levels and associated variables were analyzed. CysC levels were significantly higher in boys than in girls (0.92±0.10mg/L vs. 0.77±0.08mg/L, p<0.001). CysC was significantly correlated with serum creatinine (r=0.473, p<0.001), and serum uric acid (SUA) (r=0.546, p<0.001). Multivariable regression analysis revealed significant associations between CysC and SUA in all subjects (β=0.241, p<0.001), and in boys and girls separately (β=0.264 and 0.240, respectively, both p<0.001). Importantly, subjects with elevation of both serum CysC and SUA levels had the highest ratio of triglyceride to high-density lipoprotein cholesterol. CONCLUSIONS CysC had significant associations with both creatinine and SUA in Japanese junior high school students. The concomitant elevation of serum CysC and SUA levels was associated with subclinical lipid metabolism dysregulation, and suggested the presence of cardiometabolic risk accumulation.


PLOS ONE | 2016

Clinical Characteristics and Outcomes of Patients with High Ankle-Brachial Index from the IMPACT-ABI Study

Hitoshi Nishimura; Takashi Miura; Masatoshi Minamisawa; Yasushi Ueki; Naoyuki Abe; Naoto Hashizume; Tomoaki Mochidome; Mikiko Harada; Kunihiko Shimizu; Wataru Shoin; Koji Yoshie; Yasutaka Oguchi; Soichiro Ebisawa; Hirohiko Motoki; Atsushi Izawa; Jun Koyama; Uichi Ikeda; Koichiro Kuwahara

Background Reduced ankle–brachial index (ABI) is a predictor of cardiovascular events. However, the significance of high ABI remains poorly understood. This study aimed to assess the characteristics and outcomes of patients with high ABI. Methods The IMPACT-ABI study was a retrospective cohort study that enrolled and examined ABI in 3,131 patients hospitalized for cardiovascular disease between January 2005 and December 2012. From this cohort, 2,419 patients were identified and stratified into two groups: high ABI (> 1.4; 2.6%) and normal ABI (1.0–1.4; 97.3%). The primary endpoint was the cumulative incidence of major adverse cardiovascular events (MACE), including cardiovascular-associated death, myocardial infarction, and stroke. Results Compared with the normal ABI group, patients in the high ABI group showed significantly lower body mass index (BMI) and hemoglobin level, but had higher incidence of chronic kidney disease and hemodialysis. Multivariate logistic regression analysis revealed that hemodialysis was the strongest predictor of high ABI (odds ratio, 6.18; 95% confidence interval (CI), 3.05–12.52; P < 0.001). During the follow-up (median, 4.7 years), 172 cases of MACE occurred. Cumulative MACE incidence in patients with high ABI was significantly increased compared to that in those with normal ABI (32.5% vs. 14.5%; P = 0.005). In traditional cardiovascular risk factors-adjusted multivariate Cox proportional hazard analysis, high ABI was an independent predictor of MACE (hazard ratio, 2.07; 95% CI, 1.02–4.20; P = 0.044). Conclusion Lower BMI, chronic kidney disease, and hemodialysis are more frequent in patients with high ABI. Hemodialysis is the strongest predictor of high ABI. High ABI is a parameter that independently predicts MACE.


Circulation | 2017

Geriatric Nutritional Risk Index Predicts Cardiovascular Events in Patients at Risk for Heart Failure

Masatoshi Minamisawa; Takashi Miura; Hirohiko Motoki; Yasushi Ueki; Hitoshi Nishimura; Kunihiko Shimizu; Wataru Shoin; Mikiko Harada; Tomoaki Mochidome; Keisuke Senda; Koji Yoshie; Yasutaka Oguchi; Naoto Hashizume; Naoyuki Abe; Tatsuya Saigusa; Soichiro Ebisawa; Atsushi Izawa; Jun Koyama; Uichi Ikeda; Koichiro Kuwahara

BACKGROUND The geriatric nutritional risk index (GNRI) is a simple and objective nutritional assessment tool for elderly patients. Lower GNRI values are associated with a worse prognosis in patients with heart failure (HF). However, few data are available regarding the prognostic effect of the GNRI value for risk stratification in patients at risk for HF.Methods and Results:We retrospectively investigated 1,823 consecutive patients at risk for HF (Stage A/B) enrolled in the IMPACT-ABI Study. GNRI on admission was calculated as follows: 14.89×serum albumin (g/dL)+41.7×body mass index/22. Patients were divided into 2 groups according to the median GNRI value (107.1). The study endpoint was a composite of cardiovascular (CV) events, including CV death and hospitalization for worsening HF. Over a 4.7-year median follow-up, CV events occurred in 130 patients. In the Kaplan-Meier analysis, patients with low GNRI (<107.1, n=904) showed worse prognoses than those with high GNRI (≥107.1, n=919) (20.2% vs. 12.4%, P<0.001). In the multivariable Cox proportional hazards analysis, low GNRI was significantly associated with the incidence of CV events (hazard ratio: 1.48, 95% confidence interval: 1.02-2.14; P=0.040). CONCLUSIONS The simple and practical assessment of GNRI may be useful for predicting CV events in patients with Stage A/B HF.


Journal of Cardiology Cases | 2018

T-wave alternans in a case with systemic lupus erythematosus-related myocarditis

Mikiko Harada; Hirohiko Motoki; Yuichiro Kashima; Chie Nakamura; Naoto Hashizume; Dai Kishida; Hiroshi Imamura; Koichiro Kuwahara

A 42-year-old woman presented with fever, dyspnea, lower-leg edema, significant pulmonary congestion, pleural effusion, and severely reduced left ventricular contractions. She was resistant to treatment for heart failure, including catecholamines, furosemide, phosphodiesterase III inhibitors, and human atrial natriuretic peptide, and antibiotics failed to reduce her inflammation. She had renal dysfunction and hypocomplementemia and was positive for anti-nuclear and anti-ds-DNA antibodies. The patient was diagnosed with myocarditis and pleurisy associated with systemic lupus erythematosus (SLE). Prednisolone administration improved her general condition, reducing inflammation and improving left ventricular function. On day 1, an electrocardiography (ECG) revealed a T-wave inversion similar to a T-U complex configuration in leads II, aVF, and V3-6. By day 8, however, ECG showed prolonged corrected QT (QTc) and T-wave alternans (alternating beat-to-beat T-wave patterns) in lead V3-6. Careful ECG monitoring should be used to identify potentially fatal ventricular arrhythmias during the recovery phase of SLE-related myocarditis. <Learning objective: This was a case of significant T-wave alternans (TWA) during recovery from systemic lupus erythematosus (SLE)-related myocarditis. Fatal ventricular arrhythmia appears to be a risk during recovery from myocardial damage caused by SLE. Up to now, there have been no published case reports of TWA during this period. Patients with myocarditis should be carefully monitored for arrhythmia, even after ventricular function and inflammation have improved with prednisolone therapy.>.


International Journal of Cardiology | 2017

Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: A sub-analysis of the SHINANO registry☆

Mikiko Harada; Takashi Miura; Takahiro Kobayashi; Hideki Kobayashi; Masanori Kobayashi; Hiroyuki Nakajima; Hikaru Kimura; Hiroshi Akanuma; Eiichiro Mawatari; Toshio Sato; Shoji Hotta; Yuichi Kamiyoshi; Takuya Maruyama; Noboru Watanabe; Takayuki Eisawa; Naoto Hashizume; Soichiro Ebisawa; Yusuke Miyashita; Uichi Ikeda

BACKGROUND Prior reports have revealed that complete revascularization (CR) by percutaneous coronary intervention (PCI) decreased ischemic events. However, little is known about the efficacy of CR using PCI in elderly patients with multi-vessel coronary artery disease (CAD). We evaluated the 1-year effectiveness of CR-PCI in elderly patients (≥75years old) with multi-vessel CAD. METHODS The SHINANO Registry, a prospective, observational, multi-center, all-comer cohort study, has enrolled 1923 patients. From this registry, we recruited 322 elderly patients with multi-vessel CAD. The primary endpoint was major adverse cardiovascular events ([MACE]: all-cause mortality, myocardial infarction, and stroke). RESULTS Of the 322 elderly patients with multi-vessel CAD, 165 (51.2%) received CR and 157 (48.8%) received incomplete revascularization (ICR). MACE occurred in 44 (13.7%) patients. The incidence of MACE by survival analysis was significantly lower in the CR group than in the ICR group (7.4% vs. 21.1%, p<0.001). On multivariable Cox proportional hazards analysis of age, sex, and acute coronary syndrome (ACS), ACS and CR were independent predictors of MACE (hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.29-4.80; p=0.007, HR, 0.40; 95% CI, 0.20-0.77; p=0.007, respectively). In propensity score matching of age, sex, previous heart failure, previous intracranial bleeding, ACS, and body mass index, the MACE rate was significantly lower in the CR group than in the ICR group (7.2% vs. 18.4%, p=0.015). CONCLUSIONS Even in elderly patients over 75years old with multi-vessel CAD, CR-PCI appears to suppress mid-term ischemic events.


Internal Medicine | 2017

Ankle-brachial Index for the Prognosis of Cardiovascular Disease in Patients with Mild Renal Insufficiency

Hitoshi Nishimura; Takashi Miura; Masatoshi Minamisawa; Yasushi Ueki; Naoyuki Abe; Naoto Hashizume; Tomoaki Mochidome; Mikiko Harada; Kunihiko Shimizu; Wataru Shoin; Koji Yoshie; Yasutaka Oguchi; Soichiro Ebisawa; Hirohiko Motoki; Atsushi Izawa; Jun Koyama; Uichi Ikeda; Koichiro Kuwahara

Objective A low ankle-brachial index (ABI) is a known predictor for future cardiovascular events and mortality in patients with chronic kidney disease (CKD). While most prior studies have defined CKD as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2, recent reports have suggested that the cardiovascular risk may be increased even in early stages of renal insufficiency. We hypothesized that a low ABI may predict future cardiovascular morbidity and mortality in patients with mild impairment of the renal function. Methods The IMPACT-ABI study was a retrospective, single-center, cohort study that enrolled and obtained ABI measurements for 3,131 patients hospitalized for cardiovascular disease between January 2005 and December 2012. From this cohort, we identified 1,500 patients with mild renal insufficiency (eGFR =60-89 mL/min/1.73 m2), and stratified them into 2 groups: ABI ≤0.9 (low ABI group; 9.2%) and ABI >0.9 (90.8%). The primary outcome measured was the cumulative incidence of major adverse cardiovascular events (MACE; cardiovascular death, myocardial infarction, and stroke). Results Over a mean follow-up of 5.0 years, 101 MACE occurred. The incidence of MACE was significantly higher in patients with low ABI than in those with ABI >0.9 (30.2% vs. 14.4%, log rank p<0.001). A low ABI was associated with MACE in a univariate Cox proportional hazard analysis. A low ABI remained an independent predictor of MACE in a multivariate analysis adjusted for cardiovascular risk factors (hazard ratio (HR): 2.27; 95% confidence interval (CI): 1.33-3.86; p=0.002). Conclusion Low ABI was an independent predictor for MACE in patients with mild renal insufficiency.


Journal of the American College of Cardiology | 2016

IMPACT OF BRACHIAL-ANKLE PULSE WAVE VELOCITY ON LONG-TERM CARDIOVASCULAR EVENTS: RESULTS FROM IMPACT-ABI REGISTRY

Yasushi Ueki; Takashi Miura; Wataru Shoin; Kunihiko Shimizu; Mikiko Harada; Tomoaki Motidome; Koji Yoshie; Masatoshi Minamisawa; Yasutaka Oguchi; Naoto Hashizume; Hitoshi Nishimura; Naoyuki Abe; Soichiro Ebisawa; Hirohiko Motoki; Ayako Okada; Yuji Shiba; Atsushi Izawa; Jun Koyama; Uichi Ikeda

We evaluated the predictive value of brachial-ankle pulse wave velocity (baPWV) for cardiovascular events. The baPWV were measured in 2855 patients who admitted to our department with any cardiovascular disease. The primary endpoints were major adverse cardiovascular events (MACE; cardiovascular


Journal of the American College of Cardiology | 2016

THE ASSOCIATION BETWEEN ANKLE BRACHIAL INDEX AND 10 YEARS CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS: FROM IMPACT-ABI REGISTRY

Tomoaki Mochidome; Kunihiko Shimizu; Wataru Shoin; Mikiko Harada; Yasushi Ueki; Koji Yoshie; Masatoshi Minamisawa; Yasutaka Oguchi; Naoto Hashizume; Hitoshi Nishimura; Naoyuki Abe; Takashi Miura; Soichiro Ebisawa; Takahiro Takeuchi; Hirohiko Motoki; Ayako Okada; Yuji Shiba; Atsushi Izawa; Jun Koyama; Uichi Ikeda

Ankle Brachial Index (ABI) is used for diagnosis of peripheral artery disease and prediction of mortality with general populations. However, little is known about predictive value of ABI for long term ischemic events in hemodialysis (HD) patients. We evaluated whether ABI could predict long term

Collaboration


Dive into the Mikiko Harada's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge